![Stephen Little](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Stephen Little is the founder of DxS Ltd., which was founded in 2001.
He held the title of Chief Executive Officer in 2009.
Dr. Little's former jobs include Chief Executive Officer & Director at Yourgene Health Plc, Director & Vice President-Diagnostics at Loxbridge Research LLP, Vice President-Personalized Healthcare at QIAGEN NV, and Principal at AstraZeneca Diagnostics.
Dr. Little received a doctorate degree from Heriot-Watt University.
Eerdere bekende functies van Stephen Little
Bedrijven | Functie | Einde |
---|---|---|
DxS Ltd.
![]() DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Algemeen Directeur | 01-09-2009 |
Loxbridge Research LLP
![]() Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | - |
YOURGENE HEALTH | Algemeen Directeur | 04-07-2018 |
QIAGEN N.V. | Corporate Officer/Principal | - |
AstraZeneca Diagnostics | Corporate Officer/Principal | - |
Opleiding van Stephen Little
Heriot-Watt University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
QIAGEN N.V. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
AstraZeneca Diagnostics | |
DxS Ltd.
![]() DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Health Technology |
Yourgene Health Plc
![]() Yourgene Health Plc Medical SpecialtiesHealth Technology Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. It primarily manufactures molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. It operates through the Genomic Technologies and Genomic Services segments. The Genomic Technologies segment represents the in vitro diagnostic products, software and instrumentation manufactured by the group. The Genomic Services segment operates testing laboratories in Taiwan and the UK, and provides services to clinicians, third party clinical service providers and contract research organizations. The company was founded on April 13, 2000 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Loxbridge Research LLP
![]() Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Finance |